Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content.

导出 LinkOut

翻译打印收藏纠错

作者： E Louise,Thomas ^[1] ; Elizabeth,Potter ; Isabella,Tosi ; Julie,Fitzpatrick ; Gavin,Hamilton ; Vian,Amber ; Robert,Hughes ; Christopher,North ; Paul,Holvoet ; Mary,Seed ; D John,Betteridge ; Jimmy D,Bell ; Rossi P,Naoumova

作者单位： The Robert Steiner MR Unit, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK. louise.thomas@csc.mrc.ac.uk ^[1]

主题词脂肪组织(Adipose Tissue);成年人(Adult);双盲法(Double-Blind Method);人类(Humans);高脂血症(Hyperlipidemias);降血糖药(Hypoglycemic Agents);脂类(Lipids);肝(Liver);磁共振成像(Magnetic Resonance Imaging);男(雄)性(Male);中年人(Middle Aged);肌(Muscles);安慰剂(Placebos);噻唑烷二酮类(Thiazolidinediones)

DOI 10.1016/j.atherosclerosis.2007.03.043

PMID 17482623

发布时间 2022-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览35

Atherosclerosis

2007年195卷1期

e181-90页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content.

Atherosclerosis

相似文献

Atherosclerosis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content.

Atherosclerosis

相似文献

Atherosclerosis

相关期刊

检索历史清除